Israel Englander Karyopharm Therapeutics Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,255,264 shares of KPTI stock, worth $878,684. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,255,264

Previous 2,092,426 40.01%

Holding current value

$878,684

Previous $1.82 Million 42.8%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.06 $586,013 - $887,391	-837,162 Reduced 40.01%	1,255,264 $1.04 Million
Q2 2024 Aug 14, 2024	BUY	$0.87 - $1.58 $788,695 - $1.43 Million	906,547 Added 76.45%	2,092,426 $1.82 Million
Q1 2024 May 15, 2024	SELL	$0.72 - $1.66 $250,837 - $578,319	-348,385 Reduced 22.71%	1,185,879 $1.79 Million
Q4 2023 Feb 14, 2024	BUY	$0.68 - $1.31 $260,455 - $501,760	383,023 Added 33.27%	1,534,264 $1.32 Million
Q2 2023 Aug 14, 2023	BUY	$1.79 - $4.59 $2.04 Million - $5.22 Million	1,137,478 Added 8264.75%	1,151,241 $2.06 Million
Q1 2023 May 15, 2023	SELL	$2.84 - $3.92 $959,295 - $1.32 Million	-337,780 Reduced 96.08%	13,763 $54,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $220,365 - $526,922	88,857 Added 33.83%	351,543 $1.2 Million
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $1.4 Million - $1.99 Million	-342,697 Reduced 56.61%	262,686 $1.43 Million
Q2 2022 Aug 15, 2022	SELL	$4.15 - $8.37 $2.69 Million - $5.42 Million	-647,490 Reduced 51.68%	605,383 $2.73 Million
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $1.58 Million - $3.84 Million	-267,351 Reduced 17.59%	1,252,873 $9.23 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $7.92 Million - $13.1 Million	1,520,224 New	1,520,224 $9.78 Million
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $511,807 - $1.22 Million	-115,013 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $5.07 Million - $6.94 Million	-624,701 Reduced 84.45%	115,013 $1.19 Million
Q1 2021 May 17, 2021	SELL	$9.85 - $17.69 $17.3 Million - $31 Million	-1,755,187 Reduced 70.35%	739,714 $7.78 Million
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $33 Million - $40.1 Million	2,329,928 Added 1412.31%	2,494,901 $38.6 Million
Q3 2020 Nov 16, 2020	SELL	$14.14 - $19.71 $1.03 Million - $1.43 Million	-72,717 Reduced 30.59%	164,973 $2.41 Million
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $3.72 Million - $5.66 Million	224,194 Added 1661.19%	237,690 $4.5 Million
Q4 2019 Feb 14, 2020	SELL	$9.23 - $19.67 $11.7 Million - $25 Million	-1,272,203 Reduced 98.95%	13,496 $259,000
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $6.87 Million - $14.4 Million	1,213,044 Added 1669.59%	1,285,699 $12.4 Million
Q2 2019 Aug 15, 2019	SELL	$4.32 - $6.43 $10.7 Million - $15.9 Million	-2,467,496 Reduced 97.14%	72,655 $435,000
Q2 2019 Aug 14, 2019	SELL	$4.32 - $6.43 $775,712 - $1.15 Million	-179,563 Reduced 6.6%	2,540,151 $73.2 Million
Q1 2019 May 14, 2019	BUY	$4.12 - $10.25 $9.36 Million - $23.3 Million	2,272,107 Added 507.61%	2,719,714 $15.9 Million
Q4 2018 Feb 14, 2019	SELL	$8.2 - $16.95 $3.18 Million - $6.58 Million	-388,334 Reduced 46.45%	447,607 $4.19 Million
Q3 2018 Nov 14, 2018	SELL	$17.03 - $21.18 $3.47 Million - $4.31 Million	-203,528 Reduced 19.58%	835,941 $14.2 Million
Q2 2018 Aug 14, 2018	SELL	$12.0 - $19.88 $2.79 Million - $4.63 Million	-232,799 Reduced 18.3%	1,039,469 $17.7 Million
Q1 2018 May 15, 2018	BUY	$9.92 - $17.25 $8.29 Million - $14.4 Million	835,432 Added 191.25%	1,272,268 $17.1 Million
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $603,168 - $790,380	65,920 Added 17.77%	436,836 $4.19 Million
Q3 2017 Nov 14, 2017	BUY	$8.15 - $11.16 $3.02 Million - $4.14 Million	370,916	370,916 $4.07 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $55.9M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account